Andrew Hindman

2014

In 2014, Andrew Hindman earned a total compensation of $5.2M as Chief Business Development Officer at Acorda Therapeutics.

Compensation breakdown

Bonus$75,000
Non-Equity Incentive Plan$147,440
Option Awards$2,914,933
Salary$254,546
Stock Awards$1,685,518
Other$90,229
Total$5,167,666

Hindman received $2.9M in option awards, accounting for 56% of the total pay in 2014.

Hindman also received $75K in bonus, $147.4K in non-equity incentive plan, $254.5K in salary, $1.7M in stock awards and $90.2K in other compensation.

Rankings

In 2014, Andrew Hindman's compensation ranked 1,492nd out of 13,032 executives tracked by ExecPay. In other words, Hindman earned more than 88.6% of executives.

ClassificationRankingPercentile
All
1,492
out of 13,032
89th
Division
Manufacturing
535
out of 4,966
89th
Major group
Chemicals And Allied Products
167
out of 1,686
90th
Industry group
Drugs
132
out of 1,365
90th
Industry
Biological Products, Except Diagnostic Substances
17
out of 236
93rd
Source: SEC filing on April 21, 2017.

Hindman's colleagues

We found six more compensation records of executives who worked with Andrew Hindman at Acorda Therapeutics in 2014.

2014

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2014

Jane Wasman

Acorda Therapeutics

General Counsel

2014

Enrique Carrazana

Acorda Therapeutics

Chief Medical Officer

2014

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2014

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

2014

Michael Rogers

Acorda Therapeutics

Chief Financial Officer

News

In-depth

You may also like